Details for 2016706002
Up to date per 01.04.2026
Actions
Details for 2016706002
Granted/Registered
European Patent
20.12.2017 A
29.07.2020 B1
12.02.2015
EP
15382054
12.02.2015
EP
15382055
12.02.2015
EP
15382056
C07F 5/02 20060101AFI20160824BHEP
Owner
GlaxoSmithKline Intellectual Property (No. 2) LimitedGSK Medicines Research Centre, Gunnels Wood Road Stevenage, SG1 2NYGB
Anacor Pharmaceuticals, Inc.1020 East Meadow Circle Palo Alto, CA 94303US
Representative
Representative
Puchberger & Partner PatentanwälteReichsratsstraße 131010 WienAT
Inventor
ALEMPARTE-GALLARDO, Carlosc/o GlaxoSmithKline Parque Tecnologico de Madrid Calle Doctor Severo Ocha 28760 Tres Cantos (Madrid)ES
ALLEY, M.R.K. (dickon)c/o Anacor Pharmaceuticals Inc. 1020 East Meadow Circle Palo Alto, California 94303US
BARROS-AGUIRRE, Davidc/o GlaxoSmithKline Parque Tecnologico de Madrid Calle Doctor Severo Ocha 28760 Tres Cantos (Madrid)ES
GIORDANO, Ilariac/o GlaxoSmithKline Parque Tecnologico de Madrid Calle Doctor Severo Ocha 28760 Tres Cantos (Madrid)ES
HERNANDEZ, Vincentc/o Anacor Pharmaceuticals Inc. 1020 East Meadow Circle Palo Alto, California 94303US
LI, Xianfengc/o Anacor Pharmaceuticals Inc. 1020 East Meadow Circle Palo Alto, California 94303US
PLATTNER, Jacob J.c/o Anacor Pharmaceuticals Inc. 1020 East Meadow Circle Palo Alto, California 94303US
Information about Fees